1. Home
  2. MKSI vs RGEN Comparison

MKSI vs RGEN Comparison

Compare MKSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKSI
  • RGEN
  • Stock Information
  • Founded
  • MKSI 1961
  • RGEN 1981
  • Country
  • MKSI United States
  • RGEN United States
  • Employees
  • MKSI N/A
  • RGEN N/A
  • Industry
  • MKSI Industrial Machinery/Components
  • RGEN Medical/Dental Instruments
  • Sector
  • MKSI Industrials
  • RGEN Health Care
  • Exchange
  • MKSI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • MKSI 9.6B
  • RGEN 8.2B
  • IPO Year
  • MKSI 1999
  • RGEN N/A
  • Fundamental
  • Price
  • MKSI $107.84
  • RGEN $145.50
  • Analyst Decision
  • MKSI Buy
  • RGEN Buy
  • Analyst Count
  • MKSI 10
  • RGEN 10
  • Target Price
  • MKSI $143.30
  • RGEN $188.38
  • AVG Volume (30 Days)
  • MKSI 751.6K
  • RGEN 778.8K
  • Earning Date
  • MKSI 10-30-2024
  • RGEN 10-29-2024
  • Dividend Yield
  • MKSI 0.81%
  • RGEN N/A
  • EPS Growth
  • MKSI N/A
  • RGEN N/A
  • EPS
  • MKSI 0.12
  • RGEN N/A
  • Revenue
  • MKSI $3,580,000,000.00
  • RGEN $602,354,000.00
  • Revenue This Year
  • MKSI N/A
  • RGEN $0.08
  • Revenue Next Year
  • MKSI $10.00
  • RGEN $12.97
  • P/E Ratio
  • MKSI $910.16
  • RGEN N/A
  • Revenue Growth
  • MKSI N/A
  • RGEN N/A
  • 52 Week Low
  • MKSI $63.44
  • RGEN $110.45
  • 52 Week High
  • MKSI $147.40
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • MKSI 43.99
  • RGEN 45.65
  • Support Level
  • MKSI $105.86
  • RGEN $135.88
  • Resistance Level
  • MKSI $112.95
  • RGEN $150.72
  • Average True Range (ATR)
  • MKSI 4.33
  • RGEN 5.47
  • MACD
  • MKSI 0.11
  • RGEN -0.88
  • Stochastic Oscillator
  • MKSI 22.31
  • RGEN 36.09

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Share on Social Networks: